Northwest & Ethical Investments L.P. Zai Lab LTD Transaction History

Northwest & Ethical Investments L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jul 09, 2025	BUY	$54.9 - $105.21 $472,359 - $905,226	8,604 Added 26.71%	40,819 $2.57 Billion
Q3 2021 Jul 09, 2025	BUY	$105.0 - $178.37 $1.25 Million - $2.13 Million	11,924 Added 58.76%	32,215 $3.4 Billion
Q2 2021 Jul 09, 2025	BUY	$125.11 - $180.0 $1.47 Million - $2.11 Million	11,738 Added 137.24%	20,291 $3.59 Billion
Q1 2021 Jul 09, 2025	BUY	$126.27 - $191.71 $1.08 Million - $1.64 Million	8,553 New	8,553 $1.14 Billion

151

32.7M

168K

222K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.13B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.